Priser
Platform
Blog
Om os
Download
300705
Hunan Jiudian Pharmaceutical Co
Shenzhen Stock Exchange
0

Om

Hunan Jiudian Pharmaceuticals Co., Ltd. is a pharmaceutical manufacturer primarily focused on the research, development, production, and sale of generic drugs. The company operates within the pharmaceutical industry, contributing significantly to healthcare by providing essential medications at more affordable prices compared to brand-name counterparts. Hunan Jiudian Pharmaceuticals emphasizes high-quality manufacturing processes to ensure its medicines meet rigorous standards for safety and efficacy. The company's product portfolio covers a range of therapeutic areas, including cardiovascular diseases, infections, and gastrointestinal disorders, addressing critical health needs across diverse patient populations. Since its inception, the firm has played a crucial role in enhancing access to medicines, especially within the Asian markets it primarily serves. Through strategic partnerships and a robust supply chain network, Hunan Jiudian Pharmaceuticals not only supports public health initiatives but also contributes to the broader pharmaceutical landscape.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I HUNAN JIUDIAN PHARMACEUTICAL CO MED ENDAVU: Køb Hunan Jiudian Pharmaceutical Co ($300705) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Hunan Jiudian Pharmaceutical Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker300705
Land
Kina
Antal medarbejdere2.221
Hjemmesidehnjiudian.com
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

0,01CNH
'20
0,02CNH
'21
0,13CNH
'22
0,12CNH
'23
0,23CNH
'24
0,31CNH
'25
Ex-udbytte-dato26. maj 2025
Udbytteafkast2,42%

Analytikerskøn

Baseret på 1 analytiker

Stærkt købKøbHoldSælgStærkt sælg
0%100%0%0%0%